RETATRUTIDE - LANDMARK NEW STUDY

A bombshell new clinical trial, published in June 2025 Lancet D&E, that gives us hard data on how the most exciting peptide in the world (Retatrutide) actually changes your body composition.  Let's breakdown  what the study found, how it compares to the other “big name” weight loss drugs to defend every last ounce of lean muscle, not just lose weight.

The Study

First, let’s get into the design.

The research team ran a gold-standard, double-blind, randomized controlled trial, including a DEXA substudy piggy backing off the major retatrutide phase 2 trial for type 2 diabetes.

  • Participants: Adults with type 2 diabetes and overweight or obesity.

  • Intervention: They received weekly injections of retatrutide (at various doses, with 8 mg being the key “sweet spot”) and were tracked for 36 weeks.

What makes this study so critical is that they used DEXA scans to measure exactly how much of the weight lost was fat, and how much was muscle.

If you’ve ever dieted hard and watched your muscles deflate, you know this is the million-dollar question in the world of weight loss.

The control group included people on dulaglutide (a GLP-1–only drug) and a placebo, so we could see how retatrutide really stacks up.

The Results

So, what did they find?

At 36 weeks, participants taking 8 mg of retatrutide lost, on average, a staggering 26.1% of their total fat mass (via DEXA).

This was pure fat.

And remember, these people are changing NOTHING about their daily lives (other than just eating less because of the effects of the drug).

The lean mass (“muscle”) loss was approximately 20–40% of the total weight lost, meaning that a solid 60–80% of the weight loss was actual fat, not lean tissue.

For comparison, the control group (on dulaglutide or placebo) lost just a fraction of that.

Placebo lost approximately –4.5% of their fat mass, while dulaglutide lost about –2.6%.

Retatrutide produced the largest absolute fat loss ever recorded in an obesity/diabetes drug trial.

And it did so with about the same lean mass preservation as the “best” current drugs.

Fat vs Muscle

Every time you lose weight, even with the “miracle” GLP-1 drugs, some of it is going to be muscle, not just fat.

The proportion matters.

Losing too much muscle can tank your metabolism, weaken your strength, and set you up for a rebound.

Lose mostly fat, and you preserve your engine for the long run.

This 2025 DEXA study shows that the ratio of fat-to-muscle loss is basically the same as you’d get with tirzepatide or semaglutide, but you get way more total fat loss.

In other words, retatrutide supercharges the process without making the muscle loss any worse.

This is a game-changer, especially for anyone who wants to look, feel, and perform at their best.

 

To be a part of the clinical study and receive Retatrutide at an extremely discounted rate, click here!

 

 

8-Years In a Row!

KMM Partners

Read the latest blog on corporate health, fitness, and wellness information! Health & Fitness Blog

Read the latest blog on corporate health, fitness, and wellness information!

Print | Sitemap

© Kaiser Medical Management, 5460 Babcock, Suite 120, San Antonio, Texas 78240